Characterization of the Inflammatory Response to Severe COVID-19 Illness
2020 · American Journal of Respiratory and Critical Care Medicine · 668 citations
https://doi.org/10.1164/rccm.202005-1583oc
O
Oliver J. McElvaney
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
88
Papers
2.6K
Citations
23
h-index
37
i10-index
Oliver J. McElvaney is an academic researcher from University of Washington. The author has contributed to research in topics: Cystic Fibrosis Research Advances & Protease and Inhibitor Mechanisms & Neonatal Respiratory Health Research. The author has an h-index of 23, co-authored 75 publications.
ORCID: 0000-0001-8187-0769Papers by this author
worksα-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8
2010 · Journal of Clinical Investigation · 282 citations
https://doi.org/10.1172/jci41196
Interleukin-6: obstacles to targeting a complex cytokine in critical illness
2021 · The Lancet Respiratory Medicine · 245 citations
https://doi.org/10.1016/s2213-2600(21)00103-x
A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19
2020 · EBioMedicine · 104 citations
https://doi.org/10.1016/j.ebiom.2020.103026
Prone positioning improves oxygenation and lung recruitment in patients with SARS-CoV-2 acute respiratory distress syndrome; a single centre cohort study of 20 consecutive patients
2021 · BMC Research Notes · 36 citations
https://doi.org/10.1186/s13104-020-05426-2
International Medical Graduates and the Physician Workforce
2024 · JAMA · 28 citations
https://doi.org/10.1001/jama.2024.7656
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat